Innovative Delivery Platform Ichor Medical Systems' TriGrid™ platform offers an integrated and fully automated electroporation system for DNA drug and vaccine delivery, presenting opportunities to supply hardware components, maintenance services, and platform customization for ongoing clinical programs.

Diverse Disease Focus With applications across cancer, infectious diseases, and biodefense agents, Ichor's technology supports a broad range of therapeutic areas, enabling sales of complementary products such as biocompatible materials, electrode arrays, and adjunctive therapies tailored to specific disease targets.

Strategic Collaborations Partnerships with industry leaders like AstraZeneca, Immunomic Therapeutics, and biotech companies open avenues for joint development initiatives, licensing deals, and platform integration, increasing potential sales of research licenses, technology upgrades, and collaborative tools.

Growth and Funding Potential Although current revenue is modest, the company's expanding research collaborations and recent development efforts suggest opportunities to introduce advanced technological solutions, training services, and scalable manufacturing support to support growth in competitive biotech sectors.

Technology Stack & Infrastructure Ichor's focus on maintaining cutting-edge hardware and software systems like SuperCacher and CDN integrations indicates a need for robust IT and support services, fostering potential sales in hardware upgrades, cybersecurity, and digital infrastructure enhancement services.